Showing results (71-80 of 309) with videos related to
Sort By:
Pageof 31
Trends in Genetics : TIG|October 26, 2000
Analysing uncharted transcriptomes with SAGEV E Velculescu, B Vogelstein, K W KinzlerProceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cellsB H Park, B Vogelstein, K W KinzlerProceedings of the National Academy of Sciences of the United States of America|October 1, 1976
Molecular determinants of immunogenicity: the immunon model of immune responseH M Dintzis, R Z Dintzis, B VogelsteinThe American Journal of Pathology|July 1, 1994
Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequencesH Kim, J Jen, B Vogelstein, et al.Cancer Research|November 24, 2001
Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomasR Wu, Y Zhai, E R Fearon, et al.Science (New York, N.Y.)|July 5, 1991
p53 mutations in human cancersM Hollstein, D Sidransky, B Vogelstein, et al.Nature|June 20, 1996
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21T Waldman, C Lengauer, K W Kinzler, et al.Cancer Genetics and Cytogenetics|January 1, 1986
Gene amplification in cancer: a molecular cytogenetic approachP Meltzer, K Kinzler, B Vogelstein, et al.Molecular and Cellular Biology|July 20, 1999
Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expressionF T Kolligs, G Hu, C V Dang, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1997
Transcriptional defects underlie loss of E-cadherin expression in breast cancerX Ji, A S Woodard, D L Rimm, et al.Pageof 31